Brevan Howard Capital Management’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$62.4K	Buy	+17,148	New	+$62.4K	﹤0.01%	1714
2024 Q2	–	Sell	-81,676	Closed	-$149K	–	985
2024 Q1	$149K	Buy	+81,676	New	+$149K	﹤0.01%	800